It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screening. Editorial Article uri icon

Overview

abstract

  • The benefit-harm ratio of PSA screening can be dramatically improved by avoiding screening, biopsy and treatment in men who are unlikely to benefit, and by referring men that do need treatment to high volume centers.

publication date

  • January 4, 2014

Research

keywords

  • Early Detection of Cancer
  • Prostate
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

Identity

Scopus Document Identifier

  • 84904069931

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2013.12.049

PubMed ID

  • 24411991

Additional Document Info

volume

  • 66

issue

  • 2